Deedwania P C
Cardiol Clin. 1986 Nov;4(4):643-58.
The preceding review indicates that silent myocardial ischemia has definite prognostic implications in both symptomatic and asymptomatic patients with coronary artery disease. Patients surviving an acute myocardial infarction are at a particularly high risk if they show evidence of myocardial ischemia. At present, many noninvasive diagnostic modalities are available to the physician for the evaluation of symptomatic and silent myocardial ischemia in such patients. Because as many as 30 per cent of patients may become asymptomatic after myocardial infarction, physicians must be aggressive in evaluating their patients for the presence of silent myocardial ischemia. The presence of silent ischemia would help identify those patients at high risk of postinfarction complications. Future use of currently available therapeutic modalities directed toward treatment of total ischemic burden on the myocardium may help lower morbidity and mortality in these patients by reducing the risk of subsequent cardiac events.
上述综述表明,无症状性心肌缺血对有症状和无症状的冠心病患者均具有明确的预后意义。急性心肌梗死后存活的患者若有心肌缺血证据,则处于特别高的风险中。目前,医生有许多非侵入性诊断方法可用于评估此类患者的有症状和无症状性心肌缺血。由于多达30%的患者在心肌梗死后可能变得无症状,医生必须积极评估其患者是否存在无症状性心肌缺血。无症状性缺血的存在将有助于识别那些有心肌梗死后并发症高风险的患者。未来使用目前可用的针对心肌总缺血负荷治疗的治疗方法,可能通过降低后续心脏事件的风险,帮助降低这些患者的发病率和死亡率。